𝛼SK or Searchbullish
Hybridan Research: DXS International PLC
The Interims to 31 October 2025 reported a 2% decrease in Revenue to £1,685k and a 5% reduction in Administration Expenses to £1,618k, while Gross Margins improved marginally to 87%.
What is covered in the Full Insight:
- Introduction to DXS International PLC
- Financial Summary for Interim Period Ending October 2025
- Product and Technology Developments
- NHS Framework and Market Opportunities
- Risk Factors and Future Outlook
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 11-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Hybridan Research: DXS International PLC04 Feb 2026
x